• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

意大利归因于致癌感染的癌症死亡率估计。

Estimates of Cancer Mortality Attributable to Carcinogenic Infections in Italy.

机构信息

Center for Public Health Research, University of Milan-Bicocca, 20900 Monza, Italy.

Value-Based Healthcare Unit, IRCCS Multi Medica, 20099 Sesto San Giovanni, Italy.

出版信息

Int J Environ Res Public Health. 2020 Nov 24;17(23):8723. doi: 10.3390/ijerph17238723.

DOI:10.3390/ijerph17238723
PMID:33255366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7727788/
Abstract

Several infectious agents are ascertained causes of cancer, but the burden of cancer mortality attributable to carcinogenic infections in Italy is still unknown. To tackle this issue, we calculated the rate and regional distribution of cancer deaths due to infections sustained by seven pathogens ranked as group 1 carcinogenic agents in humans by the International Agency for Research on Cancer. Population attributable fractions related to these agents were applied to annual statistics of cancer deaths coded according to the 10th International Classification of Diseases. The estimated burden of cancer mortality attributable to carcinogenic infections in Italy during the period 2011-2015 was 8.7% of all cancer deaths registered yearly, on average. Approximately 60% of deaths occurred in men, and almost the whole burden was due to four infectious agents (, hepatitis C virus, high-risk human papillomavirus, and hepatitis B virus). The analysis of regional distribution showed a higher number of infection-related cancer deaths in the northern regions, where the estimates reached 30 (Liguria) and 28 (Friuli Venezia Giulia) deaths per 100,000 inhabitants in 2015. Since one-twelfth of cancer deaths were attributable to these modifiable risk factors, the implementation of appropriate prevention and treatment interventions may help to reduce the impact of these infections on cancer mortality.

摘要

一些传染性病原体已被确定为癌症的致病原因,但意大利因致癌性感染导致的癌症死亡率负担仍不清楚。为了解决这个问题,我们计算了 7 种病原体导致的癌症死亡人数在意大利的比例和地区分布,这些病原体被国际癌症研究机构列为第 1 组致癌物质。将这些病原体的人群归因分数应用于根据第 10 次国际疾病分类编码的每年癌症死亡的统计数据。估计意大利在 2011-2015 年期间因致癌性感染导致的癌症死亡负担占每年登记的所有癌症死亡人数的 8.7%。大约 60%的死亡发生在男性中,几乎所有的负担都归因于 4 种传染病(乙型肝炎病毒、丙型肝炎病毒、高危型人乳头瘤病毒和乙型肝炎病毒)。对地区分布的分析显示,北部地区因感染导致的癌症死亡人数较多,2015 年,该地区每 10 万人中有 30 人(利古里亚)和 28 人(弗留利-威尼斯朱利亚)死于与感染相关的癌症。由于有 1/12 的癌症死亡归因于这些可改变的危险因素,因此实施适当的预防和治疗干预措施可能有助于降低这些感染对癌症死亡率的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529a/7727788/815d7c3af34b/ijerph-17-08723-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529a/7727788/9a8706f1ee2b/ijerph-17-08723-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529a/7727788/815d7c3af34b/ijerph-17-08723-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529a/7727788/9a8706f1ee2b/ijerph-17-08723-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/529a/7727788/815d7c3af34b/ijerph-17-08723-g002a.jpg

相似文献

1
Estimates of Cancer Mortality Attributable to Carcinogenic Infections in Italy.意大利归因于致癌感染的癌症死亡率估计。
Int J Environ Res Public Health. 2020 Nov 24;17(23):8723. doi: 10.3390/ijerph17238723.
2
Estimation of Cancer Burden Attributable to Infection in Asia.亚洲因感染导致的癌症负担估计
J Epidemiol. 2015;25(10):626-38. doi: 10.2188/jea.JE20140215. Epub 2015 Sep 19.
3
Estimates of the incidence of infection-related cancers in Italy and Italian regions in 2018.2018年意大利及意大利各地区感染相关癌症发病率的估计。
J Prev Med Hyg. 2019 Dec 20;60(4):E311-E326. doi: 10.15167/2421-4248/jpmh2019.60.4.1434. eCollection 2019 Dec.
4
Burden of cancer mortality attributable to carcinogenic infections in Spain.西班牙因致癌感染导致的癌症死亡负担。
Med Clin (Barc). 2020 May 22;154(10):394-397. doi: 10.1016/j.medcli.2019.11.005. Epub 2020 Jan 25.
5
Cancers attributable to infectious agents in Italy.意大利由感染因子导致的癌症。
Eur J Cancer. 2023 Apr;183:69-78. doi: 10.1016/j.ejca.2023.01.010. Epub 2023 Jan 25.
6
The cancer burden attributable to biologic agents.生物制剂导致的癌症负担。
Ann Epidemiol. 2015 Mar;25(3):183-7. doi: 10.1016/j.annepidem.2014.11.016. Epub 2014 Nov 20.
7
Emerging Evidence for Infectious Causes of Cancer in the United States.美国癌症感染病因的新证据。
Epidemiol Rev. 2019 Jan 31;41(1):82-96. doi: 10.1093/epirev/mxz003.
8
Disparities by province, age, and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China: a comparative risk assessment.中国 23 种潜在可改变风险因素导致的特定部位癌症负担的省际、年龄和性别差异:一项比较风险评估。
Lancet Glob Health. 2019 Feb;7(2):e257-e269. doi: 10.1016/S2214-109X(18)30488-1.
9
The global health burden of infection-associated cancers in the year 2002.2002年感染相关癌症的全球健康负担。
Int J Cancer. 2006 Jun 15;118(12):3030-44. doi: 10.1002/ijc.21731.
10
Incidence of infection-associated cancers in Italy and prevention strategies.意大利感染相关癌症的发病率及预防策略。
Epidemiol Prev. 2015 Jul-Aug;39(4 Suppl 1):14-20.

引用本文的文献

1
Harnessing bacterial metabolites for enhanced cancer chemotherapy: unveiling unique therapeutic potentials.利用细菌代谢物增强癌症化疗:揭示独特的治疗潜力。
Arch Microbiol. 2024 Oct 29;206(11):449. doi: 10.1007/s00203-024-04179-x.
2
Association between Malnutrition and Depression in Patients with Cancer: The Importance of Nutritional Status Evaluation in Cancer Care.营养不良与癌症患者抑郁的相关性:癌症护理中营养状况评估的重要性。
Int J Environ Res Public Health. 2023 Jan 27;20(3):2295. doi: 10.3390/ijerph20032295.
3
Advances in Population-Based Healthcare Research: From Measures to Evidence.

本文引用的文献

1
Five insights from the Global Burden of Disease Study 2019.2019 年全球疾病负担研究的五个洞见。
Lancet. 2020 Oct 17;396(10258):1135-1159. doi: 10.1016/S0140-6736(20)31404-5.
2
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.基于 204 个国家和地区 1990 年至 2019 年卫生服务有效覆盖指数测量全民健康覆盖:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1250-1284. doi: 10.1016/S0140-6736(20)30750-9. Epub 2020 Aug 27.
3
Migrant Health Burden: Where Do We Stand?
基于人群的医疗保健研究进展:从措施到证据。
Int J Environ Res Public Health. 2022 Oct 12;19(20):13122. doi: 10.3390/ijerph192013122.
4
Prevention, diagnosis and treatment of cervical cancer: A systematic review of the impact of COVID-19 on patient care.宫颈癌的预防、诊断和治疗:COVID-19 对患者护理影响的系统评价。
Prev Med. 2022 Nov;164:107264. doi: 10.1016/j.ypmed.2022.107264. Epub 2022 Sep 20.
5
Infection in Croatian Population: Knowledge, Attitudes and Factors Influencing Incidence and Recovery.克罗地亚人群中的感染:知识、态度以及影响发病率和康复的因素
Healthcare (Basel). 2022 Apr 30;10(5):833. doi: 10.3390/healthcare10050833.
移民健康负担:我们处于什么位置?
Int J Environ Res Public Health. 2020 Apr 26;17(9):3004. doi: 10.3390/ijerph17093004.
4
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence: Results from an Italian real-life cohort (LINA cohort).丙型肝炎病毒感染的直接抗病毒治疗不会增加新发肝细胞癌的发生率:来自意大利真实队列(LINA队列)的结果。
Medicine (Baltimore). 2020 Feb;99(6):e18948. doi: 10.1097/MD.0000000000018948.
5
Burden of cancer mortality attributable to carcinogenic infections in Spain.西班牙因致癌感染导致的癌症死亡负担。
Med Clin (Barc). 2020 May 22;154(10):394-397. doi: 10.1016/j.medcli.2019.11.005. Epub 2020 Jan 25.
6
Global burden of cancer attributable to infections: the critical role of implementation science.感染所致癌症的全球负担:实施科学的关键作用。
Lancet Glob Health. 2020 Feb;8(2):e153-e154. doi: 10.1016/S2214-109X(20)30001-2.
7
Estimates of the incidence of infection-related cancers in Italy and Italian regions in 2018.2018年意大利及意大利各地区感染相关癌症发病率的估计。
J Prev Med Hyg. 2019 Dec 20;60(4):E311-E326. doi: 10.15167/2421-4248/jpmh2019.60.4.1434. eCollection 2019 Dec.
8
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis.2018 年归因于感染的癌症全球负担:全球发病率分析。
Lancet Glob Health. 2020 Feb;8(2):e180-e190. doi: 10.1016/S2214-109X(19)30488-7. Epub 2019 Dec 17.
9
Estimation of the number of HCV-positive patients in Italy.估算意大利 HCV 阳性患者数量。
PLoS One. 2019 Oct 31;14(10):e0223668. doi: 10.1371/journal.pone.0223668. eCollection 2019.
10
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study.全球、区域和国家癌症发病率、死亡率、生命损失年数、失能生存年数以及 29 种癌症组别的伤残调整生命年数:1990 至 2017 年全球疾病负担研究的系统分析。
JAMA Oncol. 2019 Dec 1;5(12):1749-1768. doi: 10.1001/jamaoncol.2019.2996.